Marchex (NASDAQ:MCHX) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Marchex (NASDAQ:MCHX) announced its quarterly earnings data on Wednesday. The technology company reported ($0.03) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.02), FiscalAI reports. The company had revenue of $10.62 million during the quarter, compared to analysts’ expectations of $10.89 million. Marchex had a negative net margin of 11.15% and a negative return on equity of 14.32%.

Here are the key takeaways from Marchex’s conference call:

• Marchex said it believes it is at a positive inflection point, with better execution, rising penetration in its customer base, and early signs that its AI strategy is creating sales momentum.
• The company reported Q1 2026 revenue of $10.6 million, with new sales and upsells partly offset by migration-related revenue pressure from moving legacy platforms to Marchex Engage.
• Management raised near-term expectations, guiding Q2 adjusted EBITDA to $1.6 million-$1.8 million and saying Q3 could reach about $2 million or more on a standalone basis, or $2.5 million or more if the Archenia deal closes.
• Marchex and Archenia are already jointly selling early AI-based products, and management said nearly half of the top customers pitched have already bought one or more offerings on a recurring or pilot basis.
• The company expects the pending Archenia acquisition to close in July 2026, pending stockholder approval, and says the combination could expand its addressable market, lift margins, and support a longer-term revenue run rate of about $60 million annually.

Marchex Price Performance

Shares of NASDAQ MCHX traded up $0.02 during midday trading on Thursday, reaching $1.62. 21,337 shares of the stock were exchanged, compared to its average volume of 15,933. Marchex has a twelve month low of $1.32 and a twelve month high of $2.31. The firm has a 50-day simple moving average of $1.56 and a two-hundred day simple moving average of $1.61.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on MCHX. Weiss Ratings reissued a “sell (d-)” rating on shares of Marchex in a research report on Tuesday, April 21st. Zacks Research raised shares of Marchex from a “strong sell” rating to a “hold” rating in a research report on Thursday, February 12th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Reduce”.

Institutional Investors Weigh In On Marchex

Hedge funds and other institutional investors have recently made changes to their positions in the company. XTX Topco Ltd acquired a new stake in shares of Marchex during the 4th quarter worth approximately $26,000. Jane Street Group LLC acquired a new stake in shares of Marchex during the 1st quarter worth approximately $30,000. Manatuck Hill Partners LLC acquired a new stake in shares of Marchex during the 2nd quarter worth approximately $88,000. Finally, Kanen Wealth Management LLC acquired a new stake in shares of Marchex during the 1st quarter worth approximately $813,000. Institutional investors and hedge funds own 73.46% of the company’s stock.

Marchex Company Profile

Marchex, Inc (NASDAQ: MCHX) operates a call data and analytics platform designed to help businesses measure and optimize customer interactions. The company’s core services include call tracking, conversational analytics and performance marketing solutions that attribute phone calls to specific advertising campaigns. By capturing and analyzing voice interactions, Marchex enables advertisers, agencies and brands to gain actionable insights into caller intent, marketing ROI and customer behavior.

Through its suite of technologies, Marchex offers real-time call monitoring, keyword spotting and AI-driven transcription to surface trends and conversion signals from inbound calls.